ESC 365 - Why, when, and for whom should we use quinidine?

EHRA Premium Access

Why, when, and for whom should we use quinidine?

Session: Current practices in the management of channelopathies

Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Speaker: Doctor C. Van Der Werf (Amsterdam, NL)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Christian Van Der Werf

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

2 presentations

1 follower

3 more presentations in this session

When does the gene guide therapy in arrhythmia syndromes?

Speaker: Professor E. Behr (London, GB)

Alternatives to the ICD in high risk LQTS and CPVT

Speaker: Associate Professor L. Crotti (Milan, IT)

State-of-the-art management of unexplained cardiac arrest

Speaker: Professor J. Brugada Terradellas (Barcelona, ES)

Access the full session

Current practices in the management of channelopathies

Speakers: Doctor C. Van Der Werf, Professor E. Behr, Associate Professor L. Crotti, Professor J. Brugada Terradellas

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources